Cargando…

Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy

BACKGROUND: To scrutinize the pretreatment prognosticators on survival and late toxicities in a homogenous cohort of nasopharyngeal carcinoma (NPC) patients treated by simultaneous integrated boost intensity-modulated radiation therapy (SIB-IMRT). METHODS: A total of 219 non-distant metastatic NPC p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yun-Hsuan, Huang, Tai-Lin, Chien, Chih-Yen, Chen, Hui-Chun, Hsu, Hsuan-Chih, Huang, Eng-Yen, Wang, Chong-Jong, Huang, Yu-Jie, Wang, Yu-Ming, Huang, Chun-Chieh, Chou, Shang-Yu, Liao, Kuan-Cho, Fang, Fu-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859644/ https://www.ncbi.nlm.nih.gov/pubmed/29554940 http://dx.doi.org/10.1186/s13014-018-0990-5

Ejemplares similares

Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis
por: Liu, Chieh-Min, et al.
Publicado: (2021)

Therapeutic outcome of nasopharyngeal carcinoma with cranial nerve palsy: a single institution experience of 104 patients
por: Huang, Chun-Chieh, et al.
Publicado: (2017)

Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma
por: Tsai, Wen-Ling, et al.
Publicado: (2014)

Long-term effects on carotid intima-media thickness after radiotherapy in patients with nasopharyngeal carcinoma
por: Huang, Tai-Lin, et al.
Publicado: (2013)

Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma
por: Yi, Junlin, et al.
Publicado: (2014)

Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis
por: Cheng, Jen-Yu, et al.
Publicado: (2020)

Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix
por: Huang, Eng-Yen, et al.
Publicado: (2012)

Quality of Life as a Mediator between Cancer Stage and Long-Term Mortality in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Radiotherapy
por: Liao, Kuan-Cho, et al.
Publicado: (2021)

Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma
por: Tao, Chang-Juan, et al.
Publicado: (2013)

Prognostic factors associated with radiotherapy for cervical cancer with computed tomography-detected para-aortic lymph node metastasis
por: Wu, Szu-Yuan, et al.
Publicado: (2014)

Pretreatment combination of platelet counts and neutrophil–lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy
por: Lin, Yu-Hsuan, et al.
Publicado: (2017)

Significant Reduction in Vertebral Artery Dose by Intensity Modulated Proton Therapy: A Pilot Study for Nasopharyngeal Carcinoma
por: Lin, Yun-Hsuan, et al.
Publicado: (2021)

Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy
por: Huang, Tai-Lin, et al.
Publicado: (2020)

Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome
por: Lee, Ching-Chih, et al.
Publicado: (2010)

Survival rate in nasopharyngeal carcinoma improved by high caseload volume: a nationwide population-based study in Taiwan
por: Lee, Ching-Chih, et al.
Publicado: (2011)

Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
por: Chou, Shang-Yu, et al.
Publicado: (2018)

Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy
por: Chao, Hsing-Lung, et al.
Publicado: (2017)

Gender Is a Significant Prognostic Factor for Upper Tract Urothelial Carcinoma: A Large Hospital-Based Cancer Registry Study in an Endemic Area
por: Huang, Chun-Chieh, et al.
Publicado: (2019)

Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Yeh, Shyh-An, et al.
Publicado: (2021)

Stereotactic body radiotherapy plus cetuximab for previously irradiated un-resectable head and neck cancer
por: Huang, Tai-Lin, et al.
Publicado: (2022)

Acute radiation dermatitis among patients with nasopharyngeal carcinoma treated with proton beam therapy: Prognostic factors and treatment outcomes
por: Fang, Ko‐Chun, et al.
Publicado: (2022)

Which nasopharyngeal cancer patients need adaptive radiotherapy?
por: Hu, Yu-Chang, et al.
Publicado: (2018)

The Clinical Impacts of Pretreatment Peripheral Blood Ratio on Lymphocytes, Monocytes, and Neutrophils Among Patients with Laryngeal/Hypopharyngeal Cancer Treated by Chemoradiation/Radiation
por: Chuang, Hui-Ching, et al.
Publicado: (2020)

Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder
por: Yen, Ju-Yu, et al.
Publicado: (2019)

Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma
por: Tao, Hengmin, et al.
Publicado: (2016)

Preventive effect and safety of Chinese herbal medicine for oral mucositis during radiotherapy in patients with head and neck cancer: Study protocol for a randomized trial
por: Cheng, Yu-Chen, et al.
Publicado: (2022)

Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours
por: Yen, Chih-Chieh, et al.
Publicado: (2023)

Psychiatric aspects of bariatric surgery
por: Yen, Yung-Chieh, et al.
Publicado: (2014)

Different Risk Target Volumes for Nasopharyngeal Carcinoma Treated with Simultaneous Integrated Boost Intensity-Modulated Radiotherapy
por: Wang, Fangzheng, et al.
Publicado: (2020)

Sixteen years post radiotherapy of nasopharyngeal carcinoma elicited multi-dysfunction along PTX and chronic kidney disease with microcytic anemia
por: Lin, Yi-Ting, et al.
Publicado: (2014)

Radiotherapy Is Associated with an Accelerated Risk of Carotid Atherosclerosis in Patients with Nasopharyngeal Carcinoma: A Nine-Year Prospective Follow-Up Study
por: Lu, Cheng-Hsien, et al.
Publicado: (2022)

Comparison of cardiovascular co-morbidities and CPAP use in patients with positional and non-positional mild obstructive sleep apnea
por: Huang, Yi-Chih, et al.
Publicado: (2014)

Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages
por: Huang, Eng-Yen, et al.
Publicado: (2018)

The Impact of Insurance and Marital Status on Survival in Patients with Nasopharyngeal Carcinoma
por: Wang, Chih-Chun, et al.
Publicado: (2020)

Evaluation of Sinonasal Outcome Test (SNOT-22) Domains in the Assessment of the Quality of Life in Patients with Nasopharyngeal Carcinoma
por: Wu, Ching-Nung, et al.
Publicado: (2023)

The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
por: Huang, Yen-Hsiang, et al.
Publicado: (2021)

Factors Predict Prolonged Wait Time and Longer Duration of Radiotherapy in Patients with Nasopharyngeal Carcinoma: A Multilevel Analysis
por: Chen, Po-Chun, et al.
Publicado: (2014)

The outbreak of COVID-19 in Taiwan in late spring 2021: combinations of specific weather conditions and related factors
por: Chang, Shih-An, et al.
Publicado: (2021)

Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma
por: Fareed, Muhammad M, et al.
Publicado: (2013)

Clinical significance of pretreatment prognostic nutritional index and lymphocyte-to-monocyte ratio in patients with advanced p16-negative oropharyngeal cancer—a retrospective study
por: Tsai, Ming-Hsien, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c15tntuu1t2s9sbaqp2v5534re